vs

Side-by-side financial comparison of Karat Packaging Inc. (KRT) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

Karat Packaging Inc. is the larger business by last-quarter revenue ($115.6M vs $87.2M, roughly 1.3× Schrodinger, Inc.). Schrodinger, Inc. runs the higher net margin — 37.3% vs 5.9%, a 31.4% gap on every dollar of revenue. On growth, Karat Packaging Inc. posted the faster year-over-year revenue change (13.7% vs -1.2%). Karat Packaging Inc. produced more free cash flow last quarter ($15.1M vs $-16.1M). Over the past eight quarters, Schrodinger, Inc.'s revenue compounded faster (54.4% CAGR vs 10.0%).

Karat Packaging Inc. is a specialty manufacturer and distributor of disposable foodservice packaging products. Its offerings include paper and plastic cups, food containers, cutlery, lids, and custom branded solutions, serving restaurant chains, cafes, catering operators, and retail foodservice clients primarily across North America.

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

KRT vs SDGR — Head-to-Head

Bigger by revenue
KRT
KRT
1.3× larger
KRT
$115.6M
$87.2M
SDGR
Growing faster (revenue YoY)
KRT
KRT
+15.0% gap
KRT
13.7%
-1.2%
SDGR
Higher net margin
SDGR
SDGR
31.4% more per $
SDGR
37.3%
5.9%
KRT
More free cash flow
KRT
KRT
$31.3M more FCF
KRT
$15.1M
$-16.1M
SDGR
Faster 2-yr revenue CAGR
SDGR
SDGR
Annualised
SDGR
54.4%
10.0%
KRT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KRT
KRT
SDGR
SDGR
Revenue
$115.6M
$87.2M
Net Profit
$6.8M
$32.5M
Gross Margin
34.0%
65.7%
Operating Margin
7.3%
-19.7%
Net Margin
5.9%
37.3%
Revenue YoY
13.7%
-1.2%
Net Profit YoY
21.3%
180.8%
EPS (diluted)
$0.34
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KRT
KRT
SDGR
SDGR
Q4 25
$115.6M
$87.2M
Q3 25
$124.5M
$54.3M
Q2 25
$124.0M
$54.8M
Q1 25
$103.6M
$59.6M
Q4 24
$101.6M
$88.3M
Q3 24
$112.8M
$35.3M
Q2 24
$112.6M
$47.3M
Q1 24
$95.6M
$36.6M
Net Profit
KRT
KRT
SDGR
SDGR
Q4 25
$6.8M
$32.5M
Q3 25
$7.3M
$-32.8M
Q2 25
$10.9M
$-43.2M
Q1 25
$6.4M
$-59.8M
Q4 24
$5.6M
$-40.2M
Q3 24
$9.1M
$-38.1M
Q2 24
$9.1M
$-54.0M
Q1 24
$6.2M
$-54.7M
Gross Margin
KRT
KRT
SDGR
SDGR
Q4 25
34.0%
65.7%
Q3 25
34.5%
51.6%
Q2 25
39.6%
47.8%
Q1 25
39.3%
52.3%
Q4 24
39.2%
72.6%
Q3 24
38.6%
50.2%
Q2 24
38.5%
66.2%
Q1 24
39.3%
51.6%
Operating Margin
KRT
KRT
SDGR
SDGR
Q4 25
7.3%
-19.7%
Q3 25
6.9%
-84.6%
Q2 25
13.3%
-96.6%
Q1 25
7.5%
-85.5%
Q4 24
7.2%
-23.5%
Q3 24
10.0%
-193.9%
Q2 24
9.9%
-111.4%
Q1 24
8.4%
-184.3%
Net Margin
KRT
KRT
SDGR
SDGR
Q4 25
5.9%
37.3%
Q3 25
5.9%
-60.4%
Q2 25
8.8%
-78.8%
Q1 25
6.2%
-100.4%
Q4 24
5.5%
-45.5%
Q3 24
8.1%
-108.1%
Q2 24
8.1%
-114.2%
Q1 24
6.4%
-149.5%
EPS (diluted)
KRT
KRT
SDGR
SDGR
Q4 25
$0.34
$0.45
Q3 25
$0.36
$-0.45
Q2 25
$0.54
$-0.59
Q1 25
$0.32
$-0.82
Q4 24
$0.28
$-0.55
Q3 24
$0.45
$-0.52
Q2 24
$0.45
$-0.74
Q1 24
$0.31
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KRT
KRT
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$37.9M
$395.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$149.4M
$364.1M
Total Assets
$287.7M
$726.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KRT
KRT
SDGR
SDGR
Q4 25
$37.9M
$395.5M
Q3 25
$44.0M
$391.2M
Q2 25
$57.0M
$450.2M
Q1 25
$56.3M
$500.3M
Q4 24
$59.9M
$352.1M
Q3 24
$60.4M
$388.7M
Q2 24
$52.1M
$377.3M
Q1 24
$46.7M
$431.1M
Stockholders' Equity
KRT
KRT
SDGR
SDGR
Q4 25
$149.4M
$364.1M
Q3 25
$154.5M
$321.4M
Q2 25
$155.8M
$342.9M
Q1 25
$153.3M
$373.5M
Q4 24
$155.6M
$421.4M
Q3 24
$157.3M
$449.4M
Q2 24
$157.7M
$474.0M
Q1 24
$154.4M
$513.7M
Total Assets
KRT
KRT
SDGR
SDGR
Q4 25
$287.7M
$726.2M
Q3 25
$302.8M
$653.7M
Q2 25
$321.0M
$688.2M
Q1 25
$312.2M
$743.0M
Q4 24
$294.5M
$823.2M
Q3 24
$306.8M
$669.3M
Q2 24
$310.7M
$688.4M
Q1 24
$279.0M
$737.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KRT
KRT
SDGR
SDGR
Operating Cash FlowLast quarter
$15.4M
$-16.1M
Free Cash FlowOCF − Capex
$15.1M
$-16.1M
FCF MarginFCF / Revenue
13.1%
-18.5%
Capex IntensityCapex / Revenue
0.2%
0.0%
Cash ConversionOCF / Net Profit
2.26×
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$33.1M
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KRT
KRT
SDGR
SDGR
Q4 25
$15.4M
$-16.1M
Q3 25
$982.0K
$-61.9M
Q2 25
$9.8M
$-52.2M
Q1 25
$7.7M
$144.1M
Q4 24
$8.3M
$-31.1M
Q3 24
$19.5M
$-33.3M
Q2 24
$13.7M
$-53.7M
Q1 24
$6.6M
$-39.3M
Free Cash Flow
KRT
KRT
SDGR
SDGR
Q4 25
$15.1M
$-16.1M
Q3 25
$736.0K
$-62.4M
Q2 25
$9.6M
$-52.5M
Q1 25
$7.6M
$143.5M
Q4 24
$8.0M
$-32.0M
Q3 24
$19.2M
$-34.6M
Q2 24
$13.4M
$-54.7M
Q1 24
$6.4M
$-43.4M
FCF Margin
KRT
KRT
SDGR
SDGR
Q4 25
13.1%
-18.5%
Q3 25
0.6%
-114.8%
Q2 25
7.7%
-95.9%
Q1 25
7.4%
240.9%
Q4 24
7.9%
-36.2%
Q3 24
17.0%
-98.0%
Q2 24
11.9%
-115.6%
Q1 24
6.7%
-118.5%
Capex Intensity
KRT
KRT
SDGR
SDGR
Q4 25
0.2%
0.0%
Q3 25
0.2%
0.9%
Q2 25
0.1%
0.6%
Q1 25
0.1%
1.0%
Q4 24
0.2%
1.0%
Q3 24
0.3%
3.8%
Q2 24
0.2%
2.1%
Q1 24
0.2%
11.2%
Cash Conversion
KRT
KRT
SDGR
SDGR
Q4 25
2.26×
-0.50×
Q3 25
0.13×
Q2 25
0.89×
Q1 25
1.21×
Q4 24
1.47×
Q3 24
2.14×
Q2 24
1.50×
Q1 24
1.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KRT
KRT

Segment breakdown not available.

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons